They Mopped the Floor Twice. No One Ever Turned Off the Tap.

On a Wednesday morning in June 2023, my oncologist looked at my scans, looked at my blood work, looked at me across his desk, and said the words I had spent fourteen months fighting to hear: “You are cancer-free.”

I had expected to cry. I had expected relief so total it would feel like surfacing from deep water. Instead, I sat in the car outside the hospital and felt — nothing. Not numbness, exactly. Something closer to disorientation. Because I did not feel free. I felt exhausted in a way sleep could not fix. I felt like I was wearing someone else’s body. My joints ached. My hair was slowly returning but my energy was not. I had lost eleven kilos, most of which, I would later learn, was muscle. My memory was unreliable in a way that frightened me. I had what oncologists call “chemo brain” — a term that makes it sound manageable, almost amusing, when what it actually feels like is a fog you cannot think your way out of.

I was cancer-free. I did not feel like myself. And nobody in the system — nobody — had a programme for the gap between those two things.

To understand why that gap frightened me as much as it did, you need to know about my mother.

My mother did everything right. She trusted her doctors completely. She completed every treatment, attended every follow-up, took every prescribed medication. Twice, medicine saved her from cancer. Twice, it returned her to a life that slowly, invisibly collapsed under the weight of what the treatment had done to her terrain — and what nobody had done to restore it.

My mother’s cancer came back because the biological terrain that had produced it in the first place — the chronic inflammatory environment, the metabolic dysfunction, the immune dysregulation — was never addressed. The tumour was removed. The terrain that grew it was left intact. This is not a failure of oncology. Oncology did its job. What was missing was the work that should have happened after. The work of restoring the terrain so it could no longer sustain what had grown in it.

My mother died at 69 — not of cancer, but of what cancer treatment, without rehabilitation, had done to her body over a decade. Severe sarcopenia. She weighed 38 kilos in her final year. Her heart, weakened by cardiotoxic chemotherapy agents and years of metabolic neglect, failed. She died of heart failure in a body that looked like it had been hollowed out — because in a very real biological sense, it had been. The treatment that saved her life slowly ended it by another route, and nobody had a map for preventing that journey.

I was forty-three years old when I was declared cancer-free. I had watched my mother’s story from beginning to end. I was not going to let mine follow the same arc.

I want to be direct about something that I feel is not discussed honestly enough with cancer patients at the moment of their declaration. “Cancer-free” is a description of what the scans cannot find. It is not a description of the state of your body. After surgery, chemotherapy, and radiation, your body has been through a controlled assault. The cancer has been eliminated, yes. But so has a significant amount of everything else.

Nobody gave me this list when I left the oncology ward. I left with a discharge summary, a follow-up schedule, and a prescription for hormone therapy. Those are the right things for my oncologist to have given me. His job is the cancer. But the list on the left — everything treatment left behind — that is a different job, and it belongs to a different speciality. One that did not exist in my care pathway until I found Dr. Gaur.

A friend in Delhi — herself a physician — sent me an article Dr. Gaur had written about the fate of inflammation in cancer survivors and the role of bioterrain in recurrence risk. I read it three times. It was the first piece of medical writing I had encountered that described, with clinical precision, the gap I was standing in. The gap between “cancer-free” and “well.”

I flew to Gurugram for a consultation two months after my declaration.

He explained what had likely happened in my mother’s case with a clarity I had been seeking for years. Chemotherapy agents, particularly the anthracyclines used in breast cancer treatment, are cardiotoxic — they cause direct mitochondrial damage to cardiac cells, leading to diastolic dysfunction that can progress silently for years after treatment ends. This is documented, studied, and known. What is less systematically practiced is the monitoring and active rehabilitation of this cardiac terrain after oncology treatment concludes. My mother’s heart failure at 69 was not a coincidence. It was a predictable consequence of a decade of unmonitored, unaddressed treatment-related cardiac stress.

The sarcopenia was equally predictable. Chemotherapy causes profound muscle wasting. Without a structured, evidence-based programme to rebuild lean mass — not just “eat well and walk” but a genuine medical rehabilitation protocol — patients lose muscle and do not recover it. Lost muscle means lost metabolic function, lost insulin sensitivity, lost bone support, lost immune reserve. My mother at 38 kilos in her final year was not ageing. She was paying the full price of a decade of treatment toxicity with no one managing the bill.

Dr. Gaur said something in that first consultation that I wrote down and have kept.

The programme Dr. Gaur designed ran in full coordination with my oncologist and my hormone therapy protocol. Nothing was changed that was not his to change. What was added was a systematic, terrain-based rehabilitation plan: rebuilding lean mass through supervised resistance training and protein-structured nutrition, restoring gut microbiome integrity, addressing the mitochondrial damage from chemotherapy, monitoring my cardiac terrain through serial echocardiography with diastolic function parameters, and reducing the chronic inflammatory burden that treatment had both left behind and, in some respects, amplified.

Progress was not instant. That is important to say honestly. The first three months were slow. Fatigue is not fixed quickly when the mitochondria themselves are damaged. But by month four, the trajectory had turned. The chemo brain — that fog I had stopped believing would lift — began to clear. Not completely, but measurably, undeniably. My lean mass started returning. My energy had a quality it had not had in two years: it was sustained, not borrowed.

I think about my mother often. I think about whether, had something like this existed in 2008, her story would have been different. Whether the second diagnosis in 2014 would have happened at all, if the terrain had been addressed after the first. Whether she would be 74 and alive today, rather than gone at 69 from a body the system saved twice and never fully rebuilt.

I cannot know. But I believe the question is worth asking — loudly, persistently, in every oncology waiting room in this country. Treatment is not the end of the story. It is the end of the first chapter. What the patient needs after — systematic, evidence-based, terrain-focused rehabilitation — is the chapter medicine has not yet written a standard for. Dr. Gaur is writing it, one patient at a time, in a clinic in Gurugram.

There are three things I now believe every cancer survivor has a right to know and a right to receive:

First: being declared cancer-free is a beginning, not an ending. The work of returning your biology to health has not started yet. It starts now.

Second: the side effects of treatment — the sarcopenia, the cardiac damage, the mitochondrial dysfunction, the cognitive fog — are not just side effects to be endured. They are terrain injuries that can be addressed, systematically, with the right framework and the right physician.

Third: the terrain that grew the cancer is still there unless someone works on it. Recurrence is not bad luck. It is, in many cases, the consequence of an unchanged biological environment meeting the passage of time. Changing that environment — turning off the tap — is the work that should begin the day treatment ends.